Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

zerohedge.com - Tyler Durden - Why 'Big Pharma' Will Never Make A Cheap Anti-Aging Drug
Why 'Big Pharma' Will Never Make A Cheap Anti-Aging Drug
Zero Hedge

For years, scientists have hypothesized that safe, cheap, generic drugs like metformin and rapamycin could slow aging, based on promising findings in animal models. But despite the evidenced hope, little has been done to see if these drugs actually…

indianexpress.com - Express News Service - CBI arrests Karnataka pharma firm MD in bribery case; seizes cash, gold
CBI arrests Karnataka pharma firm MD in bribery case; seizes cash, gold
The Indian Express

3 min read Bengaluru Make us preferred source on Google The Central Bureau of Investigation (CBI) on Thursday arrested Anurag Danayak, the managing director of state-owned Karnataka Antibiotics and Pharmaceuticals Limited (KAPL), for allegedly…

newswire.ca - Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
CNW

Issued on behalf of Helus Pharma™ Eli Lilly's agreement to acquire AtaiBeckley for up to $3.8 billion hands psychedelic medicine its first large-cap validation, and it lands on a late-stage cohort already carrying pivotal data into the back…

axios.com - Chelsea Naso - Wonder's $650m raise, Crypto.com's $20b valuation, Angelini Pharma seals rare disease buy
Wonder's $650m raise, Crypto.com's $20b valuation, Angelini Pharma seals rare disease buy
Axios

• Wonder, an NYC-based cloud kitchen company, raised $650m in Series D funding at a $9b valuation. Investors include Accel, GV, New Enterprise Associates, AllianceBernstein, ARK Invest and Kayne Anderson Rudnick Investment Management. Go…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why
Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why
MarketBeat

Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) traded up 5.3% during mid-day trading on Friday. The company traded as high as $27.76 and last traded at $27.04. 63,435 shares changed hands during trading, a decline of 84% from the…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Friday. The stock traded as high as $59.31 and last traded at $59.3330, with a volume of 347128 shares trading hands. The stock had previously closed at…

barchart.com - Jim Van Meerten - Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
Barchart.com

UroGen Pharma (URGN) has surged nearly 180% over the past year and has strong technical momentum. URGN maintains a 100% “Buy” technical opinion from Barchart. The company's revenue is projected to more than double this year and grow…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) saw an uptick in trading volume on Friday. Approximately 9,615 shares changed hands during mid-day trading, an increase of 38% from the previous session's volume…

marketbeat.com - Citigroup Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
Citigroup Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target lifted by research analysts at Citigroup from $82.00 to $93.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a 'neutral' rating on the stock.

marketbeat.com - Royalty Pharma PLC $RPRX Shares Sold by C WorldWide Group Holding A S
Royalty Pharma PLC $RPRX Shares Sold by C WorldWide Group Holding A S
MarketBeat

C WorldWide Group Holding A S trimmed its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5.5% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 661,776 shares of the biopharmaceutical…

marketbeat.com - Marks Group Wealth Management Inc Purchases New Shares in Ascendis Pharma A/S $ASND
Marks Group Wealth Management Inc Purchases New Shares in Ascendis Pharma A/S $ASND
MarketBeat

Marks Group Wealth Management Inc purchased a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…

rediff.com - Nandita Malik - Indian Stock Market Rallies: Tech Mahindra Q1 Profit Lifts IT Shares, Sensex Nifty Up
Indian Stock Market Rallies: Tech Mahindra Q1 Profit Lifts IT Shares, Sensex Nifty Up
Rediff.com

Indian benchmark indices Sensex and Nifty surged in early trade, primarily fuelled by robust buying in IT stocks following Tech Mahindra's impressive 28.4 per cent rise in consolidated net profit for the June quarter, signalling strong sector…

rediff.com - Nandita Malik - Indian Stock Market Surges: Sensex Jumps 965 Points on Blue-Chip, IT, Banking Rally
Indian Stock Market Surges: Sensex Jumps 965 Points on Blue-Chip, IT, Banking Rally
Rediff.com

Indian stock markets experienced a robust surge, with the Sensex jumping 964.58 points and the Nifty crossing the 24,330 mark, fuelled by strong buying in blue-chip, IT, and banking stocks amidst positive Q1 earnings expectations and a strategic…

upi.com - Don Jacobson - FDA approves first pill to significantly lower 'bad' cholesterol
FDA approves first pill to significantly lower 'bad' cholesterol
UPI

July 16 (UPI) -- Heralding what some are calling a revolution in cholesterol management, U.S. regulators on Thursday approved the use of pill shown to significantly reduce dangerous 'LDL-C' cholesterol in at-risk adults. The Food and Drug…

thehindu.com - The Hindu Bureau - India-U.K. CETA to spur sourcing of textiles, food produce from Telangana, help attract more GCCs
India-U.K. CETA to spur sourcing of textiles, food produce from Telangana, help attract more GCCs
The Hindu

The India–UK Comprehensive Economic and Trade Agreement (CETA) that came into force on July 15 is expected to spur demand for textiles, agri produce, spices and marine products from the Telugu States, besides making several British firms…

Receive a Daily briefing on Pharma Industry News

Get Started